Cargando…
Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment
BACKGROUND: The risk factors of papillary thyroid carcinoma (PTC) recurrence are meaningful for patients and clinicians. Tumor mutation burden (TMB) has been a biomarker for the effectiveness of immune checkpoint inhibitor (ICI) and prognosis in cancer. However, the role of TMB and its latent signif...
Autores principales: | Guo, Mengli, Chen, Zhen, Li, Yayi, Li, Sijin, Shen, Fei, Gan, Xiaoxiong, Feng, Jianhua, Cai, Wensong, Liu, Qingzhi, Xu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261145/ https://www.ncbi.nlm.nih.gov/pubmed/34248843 http://dx.doi.org/10.3389/fendo.2021.674616 |
Ejemplares similares
-
Identifying Thyroid Carcinoma-Related Genes by Integrating GWAS and eQTL Data
por: Shen, Fei, et al.
Publicado: (2021) -
Prognostic implications of the BRAF-V600(E) mutation in papillary thyroid carcinoma based on a new cut-off age stratification
por: Gan, Xiaoxiong, et al.
Publicado: (2020) -
Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020) -
The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer
por: Xia, Minqi, et al.
Publicado: (2023) -
Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer
por: Xia, Yuxiao, et al.
Publicado: (2022)